PARR heads into the final days of May with a fresh analyst upgrade colliding head-on with one of its worst weeks of the year.
This morning, Mizuho's Nitin Kumar upgraded the stock to Outperform and lifted his target to $79, a sharp reversal from his Neutral stance with a $58 target just two months ago. That move arrives as the stock has shed 8.5% this week to $56.40, and is now down 12% over the past month. The contrast is hard to ignore: the Street is turning more constructive at exactly the moment the tape is punishing the name.
The broader analyst picture leans firmly bullish. Goldman Sachs upgraded Par Pacific to Buy back in mid-April with a $77 target, and JP Morgan has maintained its Overweight with the same target. Piper Sandler and Raymond James are both in the Outperform camp. The consensus target now clusters around $72–$79, well above current levels, implying roughly 28–40% return potential from Wednesday's close. The only outlier is UBS, which sits at Neutral with a $60 target. On valuation, the stock trades on a trailing P/E of just 5.1x and an EV/EBITDA of 4.8x — the latter has compressed by roughly 0.6 turns over the past month, tracking the price lower. With EV/EBIT ranking in the 87th percentile on ORTEX factor scores, value clearly isn't the problem the market is pricing in.
Short sellers have been quietly reducing exposure, not pressing it. Short interest fell 14% over the past month, settling at 7.5% of free float — down from a local peak above 8.7% in mid-April. The borrow market offers no drama to speak of: the cost to borrow is a near-frictionless 0.42%, and availability is extraordinarily loose at over 1,400% of short interest. That means for every share currently borrowed short, roughly 14 more are sitting available in the lending pool. With the ORTEX short score easing to 43.8 — its lowest level in the recent history window — the short side looks like it is winding down rather than building a fresh case. Options traders have shifted a touch more cautious this week, with the put/call ratio climbing to 0.33, about 1.5 standard deviations above its 20-day average of 0.27. That's a mild hedge, not a panic — and the 52-week high for the PCR is 0.91, so there is plenty of headroom before the options market reads as truly defensive.
The insider tape adds a note of caution that predates this week's weakness. CEO William Monteleone sold just over 108,000 shares in mid-March, collecting north of $5.8 million across several transactions when the stock was trading in the low-to-mid $50s. CFO Shawn Flores also sold around that time. Those sales came after a notable run-up, but the combined volume and the C-suite concentration of the selling is worth keeping in context, particularly with the stock now back near those same price levels. On a 90-day net basis, insiders recorded a large positive net share figure — explained almost entirely by share awards to directors in early April rather than open-market purchases, so the headline number flatters the picture somewhat.
The earnings reaction history matters here. The last print in early May landed with a -10% gap down the next day, extending to -12.5% over the subsequent five sessions. The prior quarter similarly delivered a negative one-day reaction, though a smaller one at -7.5%. The pattern is consistent: the stock has sold off after each of its last three results. The next event is scheduled for August 5.
Peers are broadly in the same boat this week: PBF fell the hardest among refiner comparables at -9.2%, while VLO shed 6.6% and DK lost 5.9%. The sector-wide pressure suggests macro and crack-spread concerns are doing most of the damage to PARR right now, rather than anything stock-specific. The question heading into the summer is whether the margin recovery that drove the analyst upgrade cycle — Montana and Washington crack spreads reportedly tripling in Q2 — is durable enough to close the gap between where the Street thinks the stock should be and where the market is currently willing to trade it.
See the live data behind this article on ORTEX.
Open PARR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.